KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Capital Leases (2016 - 2018)

Medtronic's Capital Leases history spans 4 years, with the latest figure at $21.0 million for Q2 2018.

  • For Q2 2018, Capital Leases fell 8.7% year-over-year to $21.0 million; the TTM value through Apr 2018 reached $21.0 million, down 8.7%, while the annual FY2018 figure was $21.0 million, 8.7% down from the prior year.
  • Capital Leases for Q2 2018 was $21.0 million at Medtronic, down from $23.0 million in the prior quarter.
  • Across five years, Capital Leases topped out at $129.0 million in Q2 2015 and bottomed at $21.0 million in Q2 2018.
  • The 4-year median for Capital Leases is $71.5 million (2016), against an average of $73.4 million.
  • The largest annual shift saw Capital Leases tumbled 80.0% in 2016 before it decreased 8.7% in 2018.
  • A 4-year view of Capital Leases shows it stood at $121.0 million in 2015, then tumbled by 79.34% to $25.0 million in 2016, then decreased by 8.0% to $23.0 million in 2017, then decreased by 8.7% to $21.0 million in 2018.
  • Per Business Quant, the three most recent readings for MDT's Capital Leases are $21.0 million (Q2 2018), $23.0 million (Q2 2017), and $25.0 million (Q3 2016).